Submit manuscript...
eISSN: 2373-6372

Gastroenterology & Hepatology: Open Access

Research Article Volume 13 Issue 4

Indications and complications of balloon enteroscopy in Southwest of Iran: a 3years cross sectional survey

Pezhman Alavinejad,1 Farzad Jassemi Zergani,1 Pardis Tarahom,2 Mohammad Amin Najafi1

1Alimentary Tract Research Center, Ahvaz Jundishapur University of Medical sciences, Iran
2Medical Faculty, Ahvaz Jundishapur University of Medical sciences, Iran

Correspondence: Pezhman Alavinejad, Associate professor of Gastroenterology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, Tel + 98 9161115880, Fax + 98 6132921839

Received: July 27, 2022 | Published: August 29, 2022

Citation: Alavinejad P, Zergani FJ, Tarahom P, et al. Indications and complications of balloon enteroscopy in Southwest of Iran: a 3years cross sectional survey. Gastroenterol Hepatol Open Access. 2022;13(4):156-158. DOI: 10.15406/ghoa.2022.13.00515

Download PDF

Abstract

Introduction: The advent of capsule endoscopy (CE) and balloon-assisted Enteroscopy has changed the diagnosis and management of small intestine disorders over the past decade. The purpose of this evaluation is to review the findings of small intestine evaluation by Balloon Enteroscopy in Imam Hospital of Ahvaz between 2016 and 2019.

Method: The present study is a descriptive epidemiological study that has been conducted using the files in the archives of Ahvaz Imam Hospital on a cross-sectional basis between 2016 and 2019 on all of the cases referred to this tertiary center to perform balloon Enteroscopy about their indications and any potential complication. A questionnaire containing several sections designed to collect the following data. Part A: (Basic Information) including age, sex, date and type of admission. Part B: (Record of previous diseases and procedures) including general health profile. Part C: (Enteroscopy Process Findings) and Part D: any potential complication.

Results: Overall 42 procedures performed (29 male (69%) and 13 female (31%). The mean age of females (41.96y) was less than males (52.16y). The most common reasons for referring for Enteroscopy was Melena with unknown source (8 cases, 19%) and abdominal pain (6 cases, 14.3%). More than half of the patients (28 cases, 67%) were nonsmoker. The most common findings of Enteroscopy include peptic ulcer disease (PUD) (12 cases, 28.6%), hemorrhage from angiectasia (11 cases, 26.2%), erosive gastritis (9 cases, 21.4%) and small bowel stenosis and atrophy (7 cases, 16.7%). Among the complications after Enteroscopy, only abdominal pain was reported (2 cases, 4.76%).

Conclusion: balloon Enteroscopy is a safe procedure and useful for evaluation of source of obscure bleedings and pain of unknown origin.

Keywords: balloon enteroscopy, small intestine, obscure bleeding

Introduction

The small intestine is consider as invisible part the gastrointestinal tract because most of the small intestine is not accessible by conventional endoscopy. The advent of capsule endoscopy (CE) and balloon-assisted Enteroscopy has changed the diagnosis and management of small intestine disorders over the past decade.1 Capsule endoscopy, developed in 2001, as the primary method for endoscopic evaluation in small intestine disorders as a non-invasive and safe method for complete investigation of the small intestine. However, there are several major limitations to this approach, including the inability for therapeutic interventions and movement control.2,3 In 2001, Yamamoto et al. introduced Double-Balloon Enteroscopy (DBE) technique, which is capable of performing treatment in the small intestine. The DBE mechanism is based on the concept that small intestine traction during endoscopy prevents further development of endoscopy tube, and the use of two balloons at the tip of the enteroscope and Overtube keeps the intestinal wall and prevents the formation of subsequent rings and makes Enteroscopy easier.4 In 2007, Single-Balloon Enteroscopy Technique (SBE) introduced, in which a balloon (other than latex) has attached to the tip of a silicone over tube and is inflated and deflated by an air control system.5 This system designed to make the procedure easier.

Single Balloon Enteroscopy such as DBE performs via over tube channel and provides the ability for flushing, suctioning, sampling and therapeutic interventions such as argon plasma coagulation, injections, clips insertion, polypectomy, intestine dilation and or extraction of external foreign bodies.6 Its effectiveness and safety have shown and proved in several studies, which indicated high diagnostic performance and therapeutic potential similar to Double-Balloon Enteroscopy.5,7,8

The current cross sectional study evaluates indications, findings and potential complication of single balloon Enteroscopy in Ahvaz Imam Hospital as a tertiary referral center during 4years.

Method

The present study is a descriptive epidemiological study that has conducted using the files in the archives of Ahvaz Imam Hospital on a cross-sectional basis between 2016 and 2019 on all patients who referred to this tertiary referral center to perform Enteroscopy. The inclusion criterion include completeness of the above-mentioned files, so incomplete files were removed from the study. A form contains several sections designed to record the data including demographic characters of participants, finding during Enteroscopy and any potential complication after the procedure. The checklist sections include Part A: (Basic Information) including age, sex, date and type of admission; Part B: (Record of previous diseases and procedures) including blood pressure, coronary artery disease, diabetes Mellitus, chronic kidney disease, intestinal obstruction, gastrointestinal bleeding, abdominal pain, diarrhea and or history of Intestinal surgery; Part C: (Enteroscopy Process Findings) including adenoma, Angiectasia, pseudo-diverticula, diverticula, duodenal inflammation, stenosis & atrophy, polyps, bulging structures, leiomyoma, Ileitis, ulcers, adenocarcinoma, carcinoids, hemorrhage and or metastatic lesions. All of the procedures performed with sedation by propofol and observation of anesthesiologist.

Fundings

Overall 42 procedures performed (29 male (69%) and 13 female (31%)(. The mean age of females (41.96y) was less than males (52.16y). The most common reasons for referring for Enteroscopy was Melena with unknown source (8 cases, 19%) and abdominal pain (6 cases, 14.3%) (Table 1). More than half of the patients (28 cases, 67%) were nonsmoker. The most common findings of Enteroscopy include peptic ulcer disease (PUD) (12 cases, 28.6%), hemorrhage from angiectasia (11 cases, 26.2%), erosive gastritis (9 cases, 21.4%) and small bowel stenosis and atrophy (7 cases, 16.7%) (Table 2). Among the complications after Enteroscopy, only abdominal pain was reported (two cases, 4.76%).

Cause of enteroscopy

No. (Percentage)

 

Male

Female

Total

R/O GOO

2 (6.9%)

3 (23.1%)

5 (11.9%)

R/O Celiac Disease

1 (3.4%)

1 (7.7%)

2 (4.8%)

Anemia

6 ( 20.7 %)

3 (23.1%)

9 ( 21.4 %)

Vomiting

1 (3.4%)

0

1 (2.4%)

Diarrhea

1 (3.4%)

0

1 (2.4%)

Jejunal Intussusception

0

1 (3.4%)

1 (2.4%)

Nausea & Vomiting

1 (3.4%)

1 (3.4%)

2 (4.8%)

Abdominal Pain

4 (13.8%)

2 (15.4%)

6 (14.3%)

Jaundice

1 (3.4%)

0

1 (2.4%)

Weight Loss

4 (13.8%)

1 (7.7%)

5 (11.9%)

Melena

7 (24.1%)

1 (7.7%)

8 (19%)

Volvulus

1 (3.4%)

0

1 (2.4%)

Total

29

13

42 (100%)

Table 1 The most common reasons for Enteroscopy

Variable

No. (Percent)

Enteroscopy findings

 

Yes

No

Angiectasia

2 (4.8%)

40 (95.2%)

Diverticula

2 (4.8%)

40 (95.2%)

Duodenal Inflammation

2 (4.8%)

40 (95.2%)

Duct Stenosis & Atrophy

7 (16.7%)

35 (83.3%)

External pressure effect

3 (7.1%)

39 (92.9%)

Gastritis

9 (21.4%)

33 (78.6%)

Ulcers

12 (28.6%)

30 (71.4%)

Polyps

4 (9.5%)

38 (90.5%)

Carcinoid

1 (2.4%)

41 (97.6%)

Hemorrhage

11 (26.2%)

31 (73.8%)

Table 2 Balloon Enteroscopy findings

There was no significant relation between Enteroscopy findings and confounders such as smoking, blood pressure, coronary artery disease, and diabetes mellitus (P>0.05). However, a significant relationship observed between history of chronic renal disease and Angiectasia (P=0.03) (Table 3). Moreover, there was a significant relation between previous history of gastrointestinal bleeding and gastritis (P=0.02) and diarrhea and duodenal inflammation and ulcers (P =0.04).

Confounder

Smoking

 

HTN

 

CAD

DM

 

 

CRF

Finding

Yes

P

Yes

P

Yes

P

Yes

P

Yes

P value

Angiectasia

1/14(7.1%)

0.6

1/13(7.7%)

0.55

2/11(18.2%)

0.01

0/13

0.33

2/8 (25%)

0.003

Diverticula

2/14(14.3%)

0.04

1/13(7.7%)

0.55

1/11(9.1%)

0.43

0/13

0.33

1/8(12.5%)

0.25

Duodenitis

0/14

0.3

1/13 7.7%)

0.55

0/11

0.38

1/13 (7.7%)

0.55

0/8

0.48

Luminal stenosis

1/14 (7.1%)

0.5

0/13

0.11

3 /11 (27.3%)

0.27

2/13 (15.4%)

0.64

1/8 (12.5%)

0.95

Gastritis

2/14 (14.3%)

0.42

3/13 (23.1%)

0.86

0/11

0.04

2/13 (15.4%)

0.52

0/8

1

Ulcer

0/14

1

3/13 (23.1%)

0.59

3/11 (27.3%)

0.91

3/13 (23.1%)

0.59

3/8 (37.5%)

0.53

Polyp

1/14 (7.1%)

0.13

0/13

0.15

1/11 (9.1%)

0.95

0/13

0.15

1/8 (12.5%)

0.75

Bleeding

3/14 (21.4%)

0.62

3/13 (23.1%)

0.75

3/11 (27.3%)

0.92

3/13 (23.1%)

0.75

3/8 (37.5%)

0.41

Carcinoid

1/14 (7.1%)

0.15

1/13 (7.7%)

0.13

1/11 (9.1%)

0.08

1/13 (7.7%)

0.13

1/8 (12.5%)

0.03

Table 3 Relation between different confounders and Enteroscopy findings (HTN, hypertension (n= 13); CAD,coronary artery disease (n=11); DM, diabetes mellitus (n=13); CRF, chronic renal failure (n=8))

Discussion

Usually balloon Enteroscopy performing with deep sedation and observation of an anesthesiologist, because this procedure is time consuming and sometimes could last more than an hour.4,5 Based on clinical indication and complain of subject, it could done as antegrade or retrograde.5 According to the results, the most common reasons of requesting Enteroscopy among men was Melena (24.1%), abdominal pain and weight loss (13.8%) in descending order while among women, these indications include evaluation for gastric outlet obstruction (GOO) and anemia (23.1%). This finding was similar to a systematic review in 2011, which reported suspected GI bleeding as the most common indication of balloon Enteroscopy (62.5%), followed by symptoms/signs of small-bowel obstruction (5.8%), and Crohn's disease (5.8%).9 Also, a cross sectional study from British American Hospital within December 2012 to December 2018 reported obscure gastrointestinal bleeding as the main indication for single balloon Enteroscopy.10 The same results reported from South America in a report of multinational experience.11 Among the medical records of patients referred for Enteroscopy, abdominal pain (59.5%), history of gastrointestinal bleeding (47.6%), cardiovascular diseases (38.1%), hypertension and diabetes mellitus (31%) were the most common comorbidities which is consistent with the results of a study by Tesijokawa et al. in 2008.7 After Enteroscopy, there was not any major complication and just some degrees of abdominal pain reported in 4.8% of cases which is concordance with the study of Ramchandani et al.12 This low rate of complications have confirmed in more recent studies which prove the safety of balloon enteroscopy not only as a diagnostic method but also for therapeutic interventions.13,14

The results of current work indicate that there is a significant relationship between chronic renal failure (CRF) and Angiectasia (P=0.03). This relation is a well-known complication of CRF15 and explained by accelerated early vascular ageing process mediated by medial vascular calcification.16 Another finding was relation between history of GI bleeding and gastritis that is logistic and have confirmed in other case series.17,18 Moreover there was relation between diarrhea and duodenitis (P=0.04) which is observed in other studies.19,20 These findings could be a guide for future investigations for treatment of intestinal diseases and more accurate selection of candidates for small intestine evaluation.

Conclusion

Single balloon Enteroscopy is a safe procedure and useful for evaluation of source of obscure bleedings and pain of unknown origin with negligible complications.

Acknowledgments

This current article has derived from final thesis of Dr Pardis Tarahom for her course of general physician.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Funding

None.

References

  1. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double–balloon method. Gastrointest Endosc.2001;53(2):216–220.
  2. Iddan G, Meron G, Glukhovsky A, et al. Wireless capsule endoscopy. Nature. 2000;405(6785):417.
  3. Waterman M, Eliakim R. Capsule enteroscopy of the small intestine. Abdom Imaging. 2009;34(4):452–458.
  4. Yamamoto H, Yano T, Kita H, et al. New system of double–balloon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology. 2003;125(5):1556.
  5. Kawamura T, Yasuda K, Tanaka K, et al. Clinical evaluation of a newly developed single–balloon enteroscope. Gastrointest Endosc. 2008;68(6):1112–1116.
  6. Ohtsuka K, Kashida H, Kodama K, et al. Observation and treatment of small bowel diseases using single balloon endoscope. Gastrointest Endosc. 2008;67(5):AB271.
  7. Tsujikawa T, Saitoh Y, Andoh A, et al. Novel single–balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy. 2008;40(01):11–15.
  8. Takano N, Yamada A, Watabe H, et al. Single–balloon versus double–balloon endoscopy for achieving total enteroscopy: a randomized, controlled trial. Gastrointest Endosc. 2011;73(4):734–739.
  9. Xin L, Liao Z, Jiang YP, et al. Indications, detectability, positive findings, total enteroscopy, and complications of diagnostic double–balloon endoscopy: a systematic review of data over the first decade of use. Gastrointest Endosc. 2011;74(3):563–570.
  10. HG CC, JA CV. Single balloon enteroscopy in the management of small bowel pathology. Experience of the Small Bowel Unit–British American Hospital from December 2012 to December 2018. Revista de Gastroenterologia del Peru. 2019;39(1):27–37.
  11. Sanseverino JI, Landaeta JL, Safatle–Ribeiro AV, et al. Single Balloon Enteroscopy: Latin America Experience. Gastrointest Endosc. 2009;69(5):AB195.
  12. Ramchandani M, Reddy DN, Gupta R, et al. Diagnostic yield and therapeutic impact of single‐balloon enteroscopy: series of 106 cases. J Gastroenterol Hepatol. 2009;24(10):1631–1638.
  13. Jia Y, Michael M, Bashashati M, et al. Evaluation of the diagnostic and therapeutic utility of retrograde through–the–scope balloon enteroscopy and single–balloon enteroscopy. World J Gastrointest Endosc. 2020;12(11):459.
  14. Lu Z, Qi Y, Weng J, et al. Efficacy and safety of single–balloon versus double–balloon enteroscopy: a single–center retrospective analysis. Medical Science Monitor. Med Sci Monit. 2017;23:1933–1939.
  15. Correia J, Pinho R, Rodrigues A, et al.  Small–Bowel Angioectasias: Are They Responsible for a Real Impact on Survival? GE Port J Gastroenterol. 2022;1–7.
  16. Dai L, Schurgers LJ, Shiels PG, et al. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrology Dialysis Transplantation. 2020;35(Supplement_2):ii31–7.
  17. Cheng Y, Keita M, Si XB. Investigation on Risk Factors of Chronic Gastritis in the Population of Conakry in Guinea. Indian Journal of Pharmaceutical Sciences. 2021:1–5.
  18. Feyisa ZT, Woldeamanuel BT. Prevalence and associated risk factors of gastritis among patients visiting saint paul hospital millennium medical college, addis ababa, Ethiopia. Plos One. 2021;16(2):e0246619.
  19. Bulur A, Hacisalihoglu UP. Detailed Analysis of Rare Causes of Secondary Duodenitis in Patients Diagnosed with Endoscopic Duodenitis: A Cross–Sectional Study from a Tertiary Referral Center. Medical Bulletin of Haseki/Haseki Tip Bulteni. 2021;59(5).
  20. De Meulder S, Van de Mierop FJ. A curious case of diarrhea. Pathogenesis. 2021;2:3.
Creative Commons Attribution License

©2022 Alavinejad, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.